K
Kelasi (Shenzhen) Technology
In vitro diagnostic instrument CDMO global supplier
About Kelasi (Shenzhen) Technology
Kelasi (Shenzhen) Technology Co., Ltd., operating under the brand Keylights, is a specialized Chinese enterprise focused on the in-vitro diagnostic (IVD) sector. Since its inception, the company has concentrated on the research, development, manufacturing, and sales of IVD instruments. Over nine years, Keylights has established itself as a core partner for numerous listed and pre-listed companies, with its products utilized in over 800 well-known tertiary hospitals and clinical laboratories. The company's global footprint has expanded to include installations in the United States, Germany, France, and Spain.
Read full description
The company functions as a global Contract Development and Manufacturing Organization (CDMO) supplier and an independent brand for IVD instruments. Its business model is multifaceted, encompassing direct sales of its own branded products, OEM services for clients wanting to sell products under their own brand, and patent licensing for its core technologies in IVD instruments. Keylights targets a diverse client base that includes hospitals, clinical laboratories, reagent R&D enterprises, and medical device distributors.
Keylights boasts a product portfolio that includes open chemiluminescence analytical instrument platforms developed with completely independent intellectual property rights. The product line features various series of automated analyzers such as the Chemiluminescence Series, Immunochromatography Series, and systems for sample transportation, pipetting, and staining. These instruments are designed to be compact, efficient, and intelligent, offering features like automated sample processing, precise results, and real-time monitoring. The company also provides customized development services for diagnostic reagent manufacturers and researchers, and undertakes R&D for instruments using other analytical techniques like molecular diagnosis and immunofluorescence.
At a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- Ningbo, China
- Open positions
- None listed
- Dealroom signal
- 22.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Biotechnology, Medical Research, Research and Development, Healthcare Technologies, Health Diagnostics, Techbio, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
- Links
- Website
Latest news
Press, funding announcements and product moves mentioning Kelasi (Shenzhen) Technology.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Jan 2024 | $14M | $55M | Luxin Venture Capital · Hanchi Venture Capital | ↗ |
Growth signals
Latest recorded traffic for Kelasi (Shenzhen) Technology is 20 monthly website visits, down 97% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- LCLuxin Venture Capital
- HCHanchi Venture Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Kelasi (Shenzhen) Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Kelasi (Shenzhen) Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.





